PTGS2 and sexually transmitted disease: Some studies have suggested that HLWDD can have a therapeutic effect on VD model rats by inhibiting the mRNA expression levels of interleukin-1 beta (IL-1β), tumor necrosis factor-α (TNF-α) and cyclooxygenase-2 (COX-2).